NEPHROS INC(NEPH)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

NEPHROS INC (NEPH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NEPH at 50.4/100 on a 32-signal composite quality model, placing it at rank #1,602 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), NEPHROS INC reports quarterly revenue of $6.0M, net income of $1.2M. Top institutional holders of NEPH by reported 13-F value include WEXFORD CAPITAL, Topline Capital Management, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. NEPH trades on the Nasdaq exchange and files with the SEC under CIK 1196298. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NEPH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NEPHROS INC directly from SEC EDGAR.

AI Quality Score

50.4/100

AI Rank

#1,602

Revenue

$6.0M

Net Income

$1.2M

NEPH key financials by period

NEPHROS INC reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$18.8M$1.2M6.1%
FY 202410-K$14.2M$74.0K0.0%
FY 202310-K$14.2M$-1.6M-11.2%
FY 202210-K$10.0M-43.5%
FY 202110-K$10.2M$-3.9M-31.8%
FY 202010-K$8.6M$-4.5M-49.9%

Institutions holding NEPH

Institutional investors reporting a position in NEPHROS INC on SEC Form 13F.
InstitutionSharesValueReported
WEXFORD CAPITAL3,600,552$12.9M2026-06-30
Topline Capital Management535,698$1.9M2026-06-30
VANGUARD CAPITAL MANAGEMENT198,643$709.2K2026-06-30
MORGAN STANLEY128,915$460.2K2026-06-30
Cornerstone Capital128,700$459.5K2026-06-30
BARD ASSOCIATES118,003$421.3K2026-06-30
RENAISSANCE TECHNOLOGIES77,504$276.7K2026-06-30
GEODE CAPITAL MANAGEMENT70,263$250.9K2026-06-30
Mesirow Financial Investment Management60,000$214.2K2026-06-30
HighTower Advisors59,710$213.2K2026-06-30
NEPH

NEPHROS INC

NEPH
NasdaqSmall CapHealthcare

13F Pro Quality Score

50.4/100

Rank #1,602 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$6.02M

Net Income

Q2 2026
EDGAR

$1.20M

EPS (Diluted)

Q2 2026
EDGAR

$0.11

ROIC

Q2 2026
EDGAR

40.5%

Top Institutional Holders

as of Q2 2026
$18.97M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…